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Abstract
Ascorbic acid (vitamin C) has major effects on the intestinal uptake and utilisation of Fe in humans. The objective of the present study was
to investigate the impact of Fe on the acquisition of ascorbic acid. The strategy was to study the cellular uptake and transport of ascorbic
acid in the presence of Fe and also to observe the expression of the Na-dependent vitamin C transporter 1 (SVCT1) protein in human
intestinal Caco-2 cells. SVCT1 is involved in the cellular uptake of ascorbic acid and is therefore a candidate for playing a role in the regu-
lation of Fe utilisation. Caco-2 cells were cultured on transmembrane inserts in a three-compartment system followed by treatment with
various combinations of FeCl2.4H2O (10–20mmol/l) and sodium ascorbate (150mmol/l). ELISA and Western blot analyses revealed
that both SVCT1 and ferritin expressions were up-regulated in the presence of ascorbic acid in the basal compartment underneath the
cells (10 and 22 %, respectively). Furthermore, when cells deficient in ascorbic acid were exposed to Fe, SVCT1 expression increased
significantly (23·7 %). The increase in SVCT1 expression correlated with an increase in ascorbic acid uptake (285 %) in Fe-treated cells,
as indicated by the SVCT1 inhibitor quercetin. We conclude that Fe plays an important role in regulating the uptake of ascorbic acid in
human intestinal Caco-2 cells. This new angle could change the conceptual thinking of Fe and ascorbic acid utilisation and assist in the
treatment and prevention of ascorbic acid-deficiency syndromes such as scurvy.
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Most mammals synthesise ascorbic acid in the liver to fulfil
their nutritional requirements. The last steps of the biosyn-
thesis of ascorbic acid involve the enzyme L-gulonolactone
oxidase(1). In species such as humans and guinea pigs, the
gene for L-gulonolactone oxidase is mutated, and therefore
the bioproduction of ascorbic acid is absent(2). Humans are
completely dependent on acquiring exogenous ascorbic acid
from the diet.
Ascorbic acid is essential for the synthesis of collagen in
humans, and deficiency of ascorbic acid can lead to the
disease scurvy where collagen molecules are destabilised,
giving rise to various symptoms including haemorrhage,
myalgia and anaemia. A retrospective study by Olmedo
et al.(3) has shown that in modern industrialised societies,
scurvy is mostly a comorbid condition in already ill patients
or occurs as a complication of disorders affecting nutrition
in general. The chemical structure of ascorbate makes it a
good electron donor/acceptor, and it is this antioxidative/
pro-oxidative property for which ascorbic acid is best
known for. In the plasma, ascorbate is the primary antioxidant
and is required to prevent the peroxide-mediated oxidation of
LDL(4). Ascorbic acid is also one of the best enhancers of
the intestinal absorption of Fe in humans(5). The Fe uptake-
enhancing effect of ascorbic acid has been shown in cell studies
to be due to extracellular effects(6). In a previous study in our
laboratory, it was shown that ascorbic acid also affects the
regulation of Fe uptake by intracellular mechanisms(7).
In the present study, we examined the regulation of the
Na-dependent vitamin C transporter 1 (SVCT1) in human
intestinal Caco-2 cells in the presence or in the absence of
Fe, in order to elucidate whether Fe status affects the uptake
of ascorbate. Preliminary data suggest a synergistic relation-
ship for the uptake and utilisation of these two nutrients.
A possible intermediary in the crosstalk between Fe and ascor-
bate is protein kinase C (PKC), which has been found to play a
role in the metabolism of both Fe and ascorbic acid.
PKC is an intracellular kinase that is a mediator in several
intracellular signal transduction cascades. It is activated by
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second messengers such as cyclic AMP and diacylglycerols.
Various isoforms of PKC exist, and the b-isoform has been
shown to be activated by ferric iron bound to transferrin in
several cell types(8). Activated PKC-b phosphorylates the
Fe-responsive element-binding protein(9), which suggests
that it is involved in the regulation of the affinity of Fe-
responsive element-binding protein for its substrates transfer-
rin, Nramp2 and ferritin mRNA.
Ascorbate is actively transported into the cell interior by two
transporters: SVCT1 and SVCT2. SVCT1 is believed to be the
predominant isoform in the human intestine. This dominance
is supported by indications that SVCT1 mRNA expression is
down-regulated by the presence of ascorbate in the intestinal
lumen, while SVCT2 is unaffected(10). A second route exists for
indirectly increasing intracellular ascorbate levels. Facilitated
diffusion of oxidised ascorbate, dehydroascorbate, occurs
through the GLUT1, -3 and -4 transporters(11,12). Dehydroas-
corbate is then reduced to ascorbate inside the cell or trans-
ported across the basal membrane into the circulation by
means of these glucose transporters. It has been shown that
the ascorbate transporter SVCT1 is exclusively expressed on
the apical membrane of Caco-2 cells, and therefore does not
mediate the basal transport of ascorbate(13).
The presence of SVCT1 transporters in the apical membrane
has been shown to be regulated by PKC in transfected
monkey kidney (COS-1) cells(14). In this cell type, activated
PKC (by phorbol 12-myristate 13-acetate) leads to a decrease
in ascorbate uptake that is suggested to be caused by a
down-regulation of SVCT1 transporters at the cell surface.
To our knowledge, there are no studies on the effects of
ascorbic acid on PKC activity. Our hypothesis is that ascorbic
acid activates PKC, which leads to the down-regulation of
SVCT1 and subsequently lowers the uptake of ascorbate.
Ascorbate has been previously shown to down-regulate
SVCT1 expression in Caco-2 cells(10), which was also the
case in the present study. The major hypothesis of the present
study is that Fe affects the uptake of ascorbate. We have
focused on evaluating the involvement of the SVCT1 protein,
and we have attempted to investigate whether PKC could be
responsible for the observed effects.
Materials and methods
Materials
Plastics for cell cultivation were produced by Corning (San
Fransisco, MA, USA). Media, supplements and other reagents
for culture maintenance were produced by PAA Laboratories
(Pasching, Austria). Reagents were obtained from Sigma-
Aldrich (Schnelldorf, Germany), if otherwise not stated. For
the experiments, ascorbic acid was used in the form of
sodium ascorbate, and Fe was added as Fe(II)Cl2·4H2O.
Primary and secondary antibodies
Antibodies used in the present study were commercially
produced, tested and recommended for the application.
Rabbit anti-human SVCT1 was produced by Alpha Diagnostic
(San Antonio, CA, USA). Specificity was successfully tested by
blocking the SVCT1 antibody recognition site with a fifteen-
amino acid immunising peptide identical to a portion of the
binding region in the cytoplasmic domain of human SVCT1.
According to the manufacturer, there is no significant
homology with related transport proteins for the control
peptide. For the calculation of standard curves in the ELISA
experiments, ferritin was detected in samples of known
concentration by a rabbit anti-human ferritin antiserum
(Sigma-Aldrich). In the ELISA, the primary rabbit IgG were
detected by a goat anti-rabbit IgG b-lactamase tumour endo-
thelial marker 1 (TEM)-1 conjugate (Invitrogen, Eugene, OR,
USA). For Western blots, the secondary antibody was a goat
anti-rabbit IgG conjugated with horseradish peroxidase
(Bio-Rad, Sundbyberg, Sweden).
Cell line and cell culture
Caco-2 cells (HTB-37) were purchased from the American
Type Culture Collection (Rockville, MD, USA) at passage 19.
Stock cultures were maintained in Dulbecco’s modified
Eagle’s medium supplemented with heat-inactivated fetal
bovine serum (FBS; 16 % (v/v)) and non-essential amino
acids (0·9 % (v/v)). The cell cultures were grown at 378C in
95 % humidified air and 5 % CO2. At passages 32–41, the
cells were seeded in twelve-well plates with Transwellw poly-
carbonate inserts at 60 000 cells/insert. All experiments were
initiated 14 d after seeding. No antibiotics or antifungal
agents were used.
Cell experiments for the measurement of ascorbic acid
uptake
At 12 d after seeding, the medium was exchanged for minimal
essential medium (MEM) with Earle’s salt (E15-825; PAA) sup-
plemented with 2 % (v/v) FBS. At 24 h before the experiments,
the cells were treated in the basal compartment with MEM-
FBS, unsupplemented or supplemented with Fe (10mmol/l).
Fe is readily absorbed from this compartment into the cell.
The experiments were initiated by washing the cells in PBS
followed by incubation with Hank’s balanced salt solution
supplemented with ascorbic acid (150mmol/l) in the apical
compartment and Hank’s balanced salt solution with Fe
(10mmol/l) in the basal compartment. Care was taken to
make sure that there was no contact between the Fe- and
ascorbic acid-containing media. The cells were incubated
with these media for 2 h, after which the apical and basal
media were collected for ascorbic acid analysis. The cells
were lysed in radio-immunoprecipitation assay buffer and
divided into aliquots for total protein and ascorbic acid ana-
lyses. All samples for ascorbic acid analyses were diluted to
a final concentration of meta-phosphoric acid (3 % (v/v)),
Tris (carboxyethyl) phosphine hydrochloride (0.312 mmol/l)
and EDTA (1 mmol/l). The samples were also diluted without
Tris (carboxyethyl) phosphine hydrochloride to distinguish
between ascorbic acid and dehydroascorbic acid(15). The
ascorbic acid analyses were run by HPLC. A Jasco system
(Jasco Corporation, Tokyo, Japan) with a Jasco As-2080 Plus

















pump and autosampler Jasco As-2057 was employed. The
samples were separated using an Aquasil C18, 3mm and
150 £ 4·6 mm column (Thermo Electron Corporation, Marietta,
OH, USA). The flow rate was 0·4 ml/min. The mobile phase
was NaH2PO4 (50 mmol/l) adjusted to pH 2·8 with H3PO4
(1·5 mol/l), EDTA (200 mg/l) and methanol (2 % (v/v)).
Electrochemical detection was carried out using a Decade II
system; Antec Leyden in DC mode (flow cell: VT-03, glassy
carbon WE, 3 mm; E-cell: 800 mV v. Ag/AgCl/KCl; I-cell:
50 nA). Signal analysis was conducted using Jasco ChromPass
software ( Jasco Corporation).
Cell experiments for the investigation of protein kinase C
involvement and inhibition of sodium-dependent vitamin
C transporter 1
The basic procedure was as described in the previous section
with a few exceptions. The Fe concentration was 10 or
20mmol/l. Cells were treated with the PKC inhibitor Go
6983 (5mmol/l), the PKC activator phorbol 12-myristate 13-
acetate at 1mmol/l or the SVCT1 transport inhibitor quercetin
dihydrate (50mmol/l) for 1·5 h before the ascorbate addition.
The co-incubation lasted for 1·5 h. The inhibitors and the
activator were all dissolved in dimethyl sulphoxide. The
total concentration of dimethyl sulphoxide in the wells was
0·01 %. Dimethyl sulphoxide (0·01 %) was also given to the
cells as a control. After the co-incubations, the cells were
lysed, and intracellular ascorbate/dehydroascorbate levels
were analysed by HPLC. The apical media were analysed to
differentiate between ascorbate and dehydroascorbate levels
at the start (t ¼ 0 h) and at the end (t ¼ 1·5 h) of the
incubation. This was done to predict whether, to what
extent, the uptake could be mediated by SVCT1 (ascorbate)
or by GLUT (dehydroascorbate).
Cell experiments for the measurement of sodium-
dependent vitamin C transporter 1 expression
At 12 d post-seeding, the medium was exchanged for MEM
supplemented with 2 % (v/v) FBS (MEM-FBS). For these
experiments, the MEM used had been verified to contain no
ascorbic acid or Fe by analyses in our laboratory. The study
design was as described in a previous publication(7) with
some modifications. Briefly, on day 13, the cells were treated
on the apical side with either unsupplemented MEM-FBS
(Expts 1, 2 and 5) or MEM-FBS supplemented with ascorbic
acid (150mmol/l; Expts 3, 4 and 6). Half the plates were also
treated on the basal side of the membrane with MEM-FBS
supplemented with ascorbic acid (150mmol/l; Expts 2–6).
The experimental set-up is described in Table 1.
Before incubation with Fe in Expts 4–6, the apical medium
was exchanged for MEM, supplemented as shown in Table 1.
The integrity of the monolayer was verified by transepithelial
electric resistance. In Expt 6, the ascorbic acid-treated cells
were carefully washed in PBS to remove all apical extracellular
ascorbic acid before Fe incubation experiments. This ensured
that only intracellular ascorbate was present. In Expts 4–6, the
cells were incubated with Fe for 2 h on a rotary shaker (25 rpm
and 378C) after which they were washed in PBS. Cells were
harvested immediately from half the plates. Fresh medium
(MEM-FBS) was added to the rest of the plates, which were
incubated for a further 22 h before harvest.
Harvesting of Caco-2 cells for protein analysis
Before harvest, the medium was aspirated and the cells were
washed in PBS. Cells were lysed either immediately (t ¼ 21) or
22 h (t ¼ 43) after the removal of test solutions. Cells were
lysed in cold radio-immunoprecipitation assay buffer (Sigma-
Aldrich) containing an EDTA-free protease inhibitor cocktail
(40ml/ml; Roche, Basel, Switzerland). All lysed cell samples
were handled in a cold environment. The lysates were
divided into aliquots and frozen at 2808C for later analysis.
Total protein content was estimated in aliquots of the individ-
ual lysates by the bicinchoninic acid assay (Pierce, Stockholm,
Sweden). A commercial ferritin ELISA kit (Calbiotech, Spring
Valley, CA, USA) was used for the detection of intracellular
ferritin levels.
Direct capture ELISA for the quantification of sodium-
dependent vitamin C transporter 1 expression
The SensiFlexe ELISA development kit (Invitrogen) was used
according to the manufacturer’s instructions. The concen-
trations of antigen and primary antibodies (0·5mg/well) were
optimised to maintain a relatively low total antigen concen-
tration in order to minimise competition for binding sites.
A microplate was coated with samples diluted (1:20) in
NaHCO3 (50 mmol/l) and was then incubated overnight at
48C on a rotary shaker (20 rpm). The next day, the plate
Table 1. Description of Expts 1–6*
Incubation interval (h)
Expt no. Description Apical ascorbate (150mmol/l) Fe(II)Cl2·4H2O (20mmol/l) Basal ascorbate (150 nmol/l)
1 Control – – –
2 Control – – 0–21
3 Apical ascorbate 0–21 – 0–21
4 Apical ascorbate þ FeCl2 0–21 19–21 0–21
5 Apical FeCl2 – 19–21 0–21
6 Intracellular ascorbate þ apical FeCl2 0–19 19–21 0–21
* The experiments started at t ¼ 0 h and were terminated at t ¼ 21 h. For half the cells, lysis occurred immediately at t ¼ 21. The other half was given minimal essential
medium-fetal bovine serum and put back into the incubator for another 22 h and lysed at t ¼ 43 h.

















was drained, and the wells were washed three times with PBS-
Tween (200ml). After draining, PBS-bovine serum albumin
(200ml) was added to the wells to block unspecific binding
of the antibody to the plate. The plate was again incubated
overnight at 48C while being gently agitated. On the third
day, the plate was drained and washed three times in PBS-
Tween (200ml). After thorough draining, the wells were trea-
ted with the primary antibody (0·5mg) diluted in NaHCO3
(100ml of 50 mmol/l) and then incubated for 30 min at room
temperature. The plate was drained and washed three times
in PBS-Tween (200ml). The secondary antibody (goat anti-
rabbit IgG conjugated with b-lactamase) was diluted in PBS-
bovine serum albumin (1mg in 100ml) and added to each
well. The plate was incubated for 30 min at room temperature,
protected from light. After incubation, the plate was drained
and washed three times in PBS-Tween (200ml).
Fluorocillin Green reagent (100ml of 9mmol/l) was added
to each well and incubated for 30 min, protected from light.
b-Lactamase activity was then detected using a fluorescence
microplate reader Sapphire 2 (Tecan GmbH, Salzburg, Aus-
tria). The excitation and emission wavelengths were 490 and
525 nm, respectively. The elapsed time between the end of
the incubation step and plate reading was kept constant for
all experiments. The concentration of SVCT1 was then calcu-
lated from the standard curve and normalised against the
total protein content of each sample. All values were within
the range of the standard curve. SVCT1 expression was also
analysed by Western blot using the same method as reported
previously(7) in order to verify the results of the ELISA.
Statistics
Experiments were performed on three batches of cells within
each run, and every run was repeated on three different
occasions. In addition, each trial of SVCT1 and ferritin
expression studies was duplicated in order to lyse a set of
experiments at two time points (t ¼ 21 and 43 h). With this
design, each triplicate of control cells (ascorbate or no ascor-
bate) could always be compared against another triplicate
from the same run, giving a total of eighteen samples of con-
trol cells, verifying the reproducibility of the method. All
values are reported as means of nine individual samples
with their standard errors (n 3). The significance of differences
between treatments and their control was analysed by
Student’s unpaired two-tailed t test using Microsoft Office
Excel. Differences were considered significant at P,0·05.
Results
Ascorbic acid uptake
Ascorbic acid uptake across the apical membrane was
increased in cells supplemented with Fe (FeCl2.4H2O) in the
basal extracellular compartment compared with unsupple-
mented cells (difference of 285 %, P¼0·03; Fig. 1). Transport
of ascorbic acid across the basal membrane was also
measured. The percentage transport, calculated from the intra-
cellular ascorbate levels, across the basal membrane decreased
in cells incubated with basal Fe compared with those not trea-
ted with Fe. However, the absolute amount of ascorbic acid
transported was unchanged (0·11 v. 0·10mg ascorbate/mg pro-
tein, P.0·05; Fig. 1). The latter result could indicate that
ascorbic acid transport was already at maximum velocity,
and no further increase was possible. However, these exper-
iments need to be repeated with non-saturable concentrations
of ascorbic acid, before any firm conclusions can be drawn.
During the ascorbate uptake experiments, the apical
medium was analysed for ascorbate and dehydroascorbate.
The first set of samples (10ml) was withdrawn immediately
after the addition to the cells, and a second set of samples
(10ml) was withdrawn after 1·5 h of incubation. The results
showed that the initial samples contained 20 (SE 3) % dehydro-
ascorbate of the total ascorbate/dehydroascorbate concen-


























Basal FeCl2 No FeCl2
Fig. 1. Cellular uptake and transport of ascorbic acid. The cells were incu-
bated with Fe in the basal chamber for 24 h followed by apical treatment with
ascorbic acid (150mmol/l) lasting for 2 h. Values are means, with standard
errors represented by vertical bars (n 3). Ascorbate uptake ( ) was defined
as the measured concentration of ascorbate/dehydroascorbate in the cell
lysates. Ascorbate transport ( ) was estimated by measuring the concen-
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Fig. 2. Na-dependent vitamin C transporter 1 expression in ascorbate-
deficient cells. The cells were incubated with either ascorbate (150mmol/l,
21 h; Expt 3) or Fe(II)Cl2·4H2O (20mmol/l, 2 h; Expt 5). After finishing the
incubation, the cells were lysed immediately (t ¼ 21 h, ) or 22 h later
(t ¼ 43 h, ). The experimental design was according to Table 1, except that
no basal ascorbate was added. Values are means of nine samples, with
standard errors represented by vertical bars (n 3). * Mean values were signifi-
cantly different from that of the control cells (P,0·05).

















content was increased to 26 (SE 4) % of the total concentration
of the two measured species. The difference between the two
time points was not statistically significant. It is worth noting
that the total concentration of ascorbate and dehydroascorbate
was reduced by 18 (SE 5) % during the 1·5 h of incubation.
Sodium-dependent vitamin C transporter 1 expression
When ascorbate-deficient cells were exposed to apical Fe
(Expt 5), SVCT1 protein expression increased by 23·7 (SE
5) % (P¼0·02) v. control cells (Expt 1) at t ¼ 43 h. This
increase was detectable at t ¼ 21 h, 2 h after the addition of
Fe (9 (SE 2) %, P¼0·05; Fig. 2, Expt 5). This result suggests
that the regulation of SVCT1 expression by Fe could be a rela-
tively fast response compared with, for example, ferritin
expression. Ferritin is regulated at the mRNA level by the
Fe-responsive element/Fe-regulatory protein pathway, where
the effect of Fe administration is not apparent after 2 h.
SVCT1 mRNA does not show any significant sequence simi-
larities with iron-responsive element (IRE) sequences from
ferritin or ferroportin mRNA according to the Internet-based
nucleotide Basic Local Alignment Search Tool (Blastn;
National Center of Biotechnology Information, Bethesda,
MD, USA). SVCT1 expression was significantly decreased 2 h
after the apical addition of ascorbic acid to ascorbic acid-
deficient cells (22·4 (SE 2) %, P¼0·05; Fig. 2, Expt 3). However,
after 22 h with unsupplemented medium, the levels of SVCT1
were normalised, which further supports a fast regulatory
mechanism.
The ascorbic acid transporter protein SVCT1 was slightly
up-regulated (10 (SE 2) %, P¼0·05) in the presence of basal
ascorbic acid as observed at t ¼ 21 h (Fig. 3, Expt 2). Caco-2
cells with replete ascorbic acid levels did only moderately
respond to apical treatments with ascorbate and/or Fe
(25·25 (SE 4) %, Fig. 3, Expt 4, t ¼ 43 h, P¼0·05; Expts 5–6;
no significant changes; P.0·05). The relatively weak response
(Expts 4–6) suggests that the effect of Fe on ascorbic acid
uptake is dependent on the availability and/or cellular status
of ascorbic acid. However, in Expt 4 where the change was
significant, the ferritin levels were higher than in Expts 5–6.
It should also be remembered that a relatively small change
in total SVCT1 levels might give rise to a considerably
higher response in ascorbic acid uptake.
To verify the ELISA results, SVCT1 expression was also
estimated by Western blot analyses for random samples of
treatment and controls. The Western blots showed an increase
in SVCT1 expression when ascorbic acid-depleted cells
exposed to apical Fe were analysed at t ¼ 21 h and had an
even greater increase at t ¼ 43 h (data not shown), verifying
the trends measured by ELISA (Fig. 2, Expts 1 and 5). The cor-
relation between the increased ascorbate uptake and the
increased SVCT1 expression was evidenced by treating the
cells with the reversible SVCT1 inhibitor quercetin. Quercetin
(50mmol/l) decreased the uptake of ascorbate in Fe-treated
cells by 68 % (1·34 (SE 0·07) v. 0·4 (SE 0·05)mg/mg protein,
P¼0·00001).
Possible involvement of protein kinase C
PKC inhibition by Go 6983 did not increase ascorbate uptake.
Indeed, Go 6983 decreased ascorbate uptake by 20 (SE 5) %
(P¼0·04) regardless of Fe status. PKC activation by phorbol
12-myristate 13-acetate decreased ascorbate uptake signifi-
cantly, as expected, by 84 % (data not shown) irrespective of
Fe status, suggesting that the Fe- stimulatory effect of ascor-
bate uptake is not facilitated by changes in PKC-mediated traf-
ficking. Phorbol 12-myristate 13-acetate has been shown to
affect PKC-stimulated trafficking from the cell surface to the
cytosol(14) and vice versa(16). The results of the present exper-
iments do not necessarily exclude the involvement of PKC
isoforms in Fe-stimulated ascorbate uptake. Further studies



















































Fig. 3. Ferritin and Na-dependent vitamin C transporter (SVCT1) expression in ascorbate-replete cells. Ferritin and SVCT1 protein expression in Caco-2 cells
grown on inserts. Ferritin values have been divided by 500 ( ). The medium in the basal chambers was supplemented with ascorbate (150mmol/l, Expts 2–6).
See Table 1 for an explanation of the different combinations of Fe and ascorbate used in each experiment. After finishing 2 h of Fe incubation, the cells were
lysed immediately (SVCT1 at t ¼ 21 h, ) or 22 h later (SVCT1 at t ¼ 43 h, ). Values are means of nine samples, with standard errors represented by vertical
bars. * Mean values were significantly different from that of the control cells (with basal ascorbate; P,0·05).


















Caco-2 cells grown on inserts with ascorbate in the basal com-
partment showed significantly higher baseline ferritin
expression (22 (SE 7) %; P¼0·05) compared with cells grown
without ascorbate in the basal chamber (Fig. 3, Expts 1 and
2). In contrast, when cells basally replete for ascorbate were
treated with ascorbate at the apical cell membrane, ferritin
expression was significantly down-regulated by 37 (SE 1) %
(P¼0·04; Fig. 3, Expt 3). The results for Expts 1–3 (Fig. 3)
are in accordance with the previous data from our laboratory
(N. M. S. and A.-S. S., unpublished results), suggesting that the
effect of ascorbate at the apical membrane is different from the
effect at the basolateral surface. The apical membrane was
found to be impermeable to ascorbate leaving the cell. The
findings were confirmed by the analysis of the basal, intra-
cellular and apical compartments of ascorbate-replete control
cells. HPLC analysis showed that only the apical medium was
devoid of ascorbate.
In the present study, when the Caco-2 cells were supplied
with basal ascorbate, there was no observable difference in
ferritin levels between cells that were treated with apical Fe
(Fig. 3, Expt 5) and those treated with intracellular ascorbate
and apical Fe (Fig. 3, Expt 6). Due to the earlier observed
transport of ascorbate from the basal chamber to the cell
interior, this outcome was expected as the treatments were
effectively the same. The basal influx of ascorbate is likely
to be mediated by the GLUT 1, -3 and -4 transporters, which
normally function as glucose transporters but which also
transport dehydroascorbate(13).
Discussion
There have been many studies on Fe metabolism and the
importance of maintaining an adequate Fe status in humans.
For many years, there have been general recommendations
to ingest ascorbic acid in order to stimulate Fe uptake in the
small intestine. In the present study, we have demonstrated
the involvement of Fe in the up-regulation of the vitamin C
transporter protein SVCT1 in ascorbate-depleted human intes-
tinal Caco-2 cells. We have also shown that ascorbic acid
uptake was increased if intracellular Fe levels were increased,
and we have proved the correlation between the increased
expression of the SVCT1 transporter and ascorbic acid
uptake. These results are important as they change our view
of the relationship between ascorbic acid and Fe intake.
A study by Nu´n˜ez et al.(17) has shown that the extracellular
availability of Fe determines whether the Fe influx and efflux
transporters Nramp2 and ferroportin will localise to the apical
or the basal membrane in Caco-2 cells. The consequence of
this mechanism for the present study is that both apical and
basal supplementation of Fe will contribute to an increase in
intracellular Fe concentration caused by apical or basal
influx via Nramp2. The basal influx of Fe is also affected by
transferrin originating from the FBS-supplemented medium.
In the present study, total cellular SVCT1 expression
increased by approximately 24 %, when the cells were
exposed to Fe. This measurement was made 22 h after an Fe
uptake experiment that lasted for 2 h in total. In contrast, an
increase in ascorbic acid uptake of 285 % was observed after
basal Fe supplementation for 24 h. This difference in exper-
imental design could possibly explain the very pronounced
effect that Fe supplementation had on ascorbic acid uptake
compared with the effect on SVCT1 protein expression.
There could also be other regulatory mechanisms that affect
the effective uptake of ascorbic acid, such as increased trans-
port capacity or intracellular redistribution, which is a
common mechanism for other transmembrane transport sys-
tems, for instance Nramp2 and ferroportin-1 as described ear-
lier(17). However, we observed an effect on the total protein
expression of SVCT1 when cells were exposed to Fe.
A study by MacDonald et al.(10) has shown that an increase
in the extracellular ascorbate level leads to the down-
regulation of SVCT1 mRNA in Caco-2 cells. In the present
study, we found an initial decrease, on the protein level, that
normalised after approximately 24 h. The results reported by
MacDonald et al. might lead to the conclusion that the regulat-
ory effect of ascorbate on SVCT1 takes place at the mRNA
level. As observed in the present study, the cellular response
at the protein level occurred so rapidly that it seems likely that
the regulation of SVCT1 also occurs at the translational level.
We conclude that Fe stimulates the uptake of ascorbate and
the expression of the SVCT1 transporter protein in human
Caco-2 cells. This stimulatory effect is greater when the
ascorbic acid level in the cell is low.
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